Brain target sites for 1,25-dihydroxyvitamin D3

Science. 1982 Mar 12;215(4538):1403-5. doi: 10.1126/science.6977846.

Abstract

Autoradiographic studies with 3H-labeled 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] demonstrate, in certain neurons of rat forebrain, hindbrain, and spinal cord, a nuclear retention and concentration of radioactivity, which can be prevented by treatment with 1,25(OH)2D3, but not with 25-hydroxyvitamin D3. These results indicate the presence of brain receptors in addition to pituitary receptors for 1,25(OH)2D3 and suggest a central modulation of calcium homeostasis and other central effects for this hormone. The existence of a brain-pituitary axis for certain 1,25(OH)2D3-mediated endocrine-autonomic effects is postulated.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 25-Hydroxyvitamin D 2
  • Amygdala / metabolism
  • Animals
  • Brain / metabolism*
  • Calcium / metabolism
  • Dihydroxycholecalciferols / metabolism*
  • Ergocalciferols / analogs & derivatives
  • Ergocalciferols / metabolism
  • Homeostasis
  • Hydroxycholecalciferols / metabolism*
  • Male
  • Neurons / metabolism
  • Rats
  • Spinal Cord / metabolism

Substances

  • Dihydroxycholecalciferols
  • Ergocalciferols
  • Hydroxycholecalciferols
  • 25-Hydroxyvitamin D 2
  • Calcium